Effects of estradiol, angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle in old female rats

Clinical and Experimental Hypertension

Volumn 32, Issue 2, 2010, Pages 76-83

  Guo, Qi ^a   Minami, Naoyoshi ^a   Mori, Nobuyoshi ^a   Nagasaka, Makoto ^a   Ito, Osamu ^a   Kurosawa, Hajime ^a   Kanazawa, Masayuki ^a   Kohzuki, Masahiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Estradiol; Exercise capacity; Old female rats; Skeletal muscle

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; EXERCISE; FEMALE; GASTROCNEMIUS MUSCLE; NONHUMAN; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; TREADMILL; TREATMENT DURATION; TREATMENT RESPONSE; WISTAR KYOTO RAT;

AGING; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BODY COMPOSITION; ESTRADIOL; FEMALE; MODELS, ANIMAL; MUSCLE, SKELETAL; PERINDOPRIL; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL EXERTION; RATS; RATS, INBRED WKY;

EID: 77950846713     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960902993046     Document Type: Article

References (45)

1. Mercuro G, Saiu F, Deidda M, et al. Impairment of physical exercise capacity in healthy postmenopausal women. Am Heart J 2006;151:923-927.
2. Zimmerman SD, McCormick RJ, Vadlamudi RK, Thomas DP. Age and training alter collagen characteristics in fastand slow-twitch rat limb muscle. J Appl Physiol 1993;75: 1670-1674.
3. Thomas DR. Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007;26:389-399.
4. Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA 2003;290:1600-1607.
5. Redberg RF, Nishino M, McElhinney DB, Dae MW, Botvinick EH. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease. Am Heart J 2000;139:739-744.
6. Ozdemir K, Celik C, Altunkeser BB, et al. Effect of postmenopausal hormone replacement therapy on cardiovascular performance. Maturitas 2004;47:107-113.
7. Kirwan LD, MacLusky NJ, Shapiro HM, et al. Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women. J Clin Endocrinol Metab 2004;89:1618-1629.
8. Uusi-Rasi K, Beck TJ, Sievanen H, Heinonen A, Vuori I. Associations of hormone replacement therapy with bone structure and physical performance among postmenopausal women. Bone 2003;32:704-710.
9. Tostes RC, Nigro D, Fortes ZB, Carvalho MH. Effects of estrogen on the vascular system. Braz J Med Biol Res 2003; 36:1143-1158.
10. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004;109:672-693. (Pubitemid 38198877)
11. Wagner PD. Determinants of maximal oxygen transport and utilization. Ann Rev Physiol 1996;58:21-50.
12. Wang YX, Zhang CL, Yu RT, et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004;2:1532-1539.
13. Parini P, Angelin B, Stavreus-Evers A, et al. Biphasic effects of the natural estrogen 17beta-estradiol on hepatic cholesterol metabolism in intact female rats. Arterioscler Thromb Vasc Biol 2000;20:1817-1823.
14. Mifsud SA, Skinner SL, Cooper ME, Kelly DJ, Wilkinson- Berka JL. Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats. J Am Soc Nephrol 2002;13:684-692.
15. Lawler JM, Powers SK, Hammeren J, Martin AD. Oxygen cost of treadmill running in 24-month-old Fischer-344 rats. Med Sci Sports Exerc 1993;25:1259-1264.
16. Minami N, Li Y, Guo Q, et al. Effects of angiotensinconverting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle. J Hypertens 2007;25:1241-1248.
17. Koch LG, Green CL, Lee AD, et al. Test of the principle of initial value in rat genetic models of exercise capacity. Am J Physiol Regul Integr Comp Physiol 2005;288:R466-R472.
18. Guo Q, Minami N, Mori N, et al. Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats. Hypertens Res 2008;31:525-533.
19. Gimenez J, Garcia PM, Bonacasa B, et al. Effects of oestrogen treatment and angiotensin-converting enzyme inhibition on the microvasculature of ovariectomized spontaneously hypertensive rats. Exp Physiol 2006;91:261-268.
20. Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003;107: 3059-3065.
21. Koike H, Karas RH, Baur WE, O'Donnell TF, Jr, Mendelsohn ME. Differential-display polymerase chain reaction identifies nucleophosmin as an estrogen-regulated gene in human vascular smooth muscle cells. J Vasc Surg 1996;23: 477-482.
22. Silvestre JS, Bergaya S, Tamarat R, et al. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. Circ Res 2001;89:678-683.
23. Ma W, Tan J, Matsumoto H, et al. Adult tissue angiogenesis: evidence for negative regulation by estrogen in the uterus. Mol Endocrinol 2001;15:1983-1992.
24. Gavin TP, Spector DA, Wagner H, Breen EC, Wagner PD. Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise. J Appl Physiol 2000;88:1690-1697.
25. Prewitt RL, Chen, II, Dowell R. Development of microvascular rarefaction in the spontaneously hypertensive rat. Am J Physiol 1982;243:H243-H251.
26. Mitchell ML, Byrnes WC, Mazzeo RS. A comparison of skeletal muscle morphology with training between young and old Fischer 344 rats. Mech Ageing Dev 1991;58:21-35.
27. Rossiter HB, Howlett RA, Holcombe HH, et al. Age is no barrier to muscle structural, biochemical and angiogenic adaptations to training up to 24 months in female rats. J Physiol 2005;565:993-1005.
28. Degens H, Veerkamp JH, van Moerkerk HT, et al. Metabolic capacity, fibre type area and capillarization of rat plantaris muscle. Effects of age, overload and training and relationship with fatigue resistance. Int J Biochem 1993;25:1141-1148.
29. Kyriakides ZS, Petinakis P, Kaklamanis L, et al. Gender does not influence angiogenesis and arteriogenesis in a rabbit model of chronic hind limb ischemia. Int J Cardiol 2003; 92:83-91.
30. Andersen P. Capillary density in skeletal muscle of man. Acta Physiol Scand 1975;95:203-205.
31. McCormick KM, Burns KL, Piccone CM, Gosselin LE, Brazeau GA. Effects of ovariectomy and estrogen on skeletal muscle function in growing rats. J Muscle Res Cell Motil 2004;25:21-27.
32. Kobori M, Yamamuro T. Effects of gonadectomy and estrogen administration on rat skeletal muscle. Clin Orthop Relat Res 1989:306-311.
33. Kovanen V, Suominen H. Effects of age and life-time physical training on fibre composition of slow and fast skeletal muscle in rats. Pflugers Arch 1987;408:543-551.
34. Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002;418:797-801.
35. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 2003;95:960-968.
36. Winder WW. Energy-sensing and signaling by AMPactivated protein kinase in skeletal muscle. J Appl Physiol 2001;91:1017-1028.
37. Zhang X, Xie YW, Nasjletti A, et al. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 1997;95:176-182.
38. Shen W, Hintze TH, Wolin MS. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 1995;92:3505-3512.
39. Bahi L, Koulmann N, Sanchez H, et al. Does ACE inhibition enhance endurance performance and muscle energy metabolism in rats? J Appl Physiol 2004;96:59-64.
40. Levy BI, Michel JB, Salzmann JL, et al. Long-term effects of angiotensin-converting enzyme inhibition on the arterial wall of adult spontaneously hypertensive rats. Am J Cardiol 1993; 71:8E-16E.
41. Toritsuka N, Tsukidate K, Igarashi T. Mechanism of weight gain suppressing effect of ER-40133, an angiotensin I converting enzyme inhibitor, in growing rats. J Toxicol Sci 1999; 24:45-53.
42. Black MJ, Bertram JF, Johnston CI. Effect of angiotensinconverting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat. J Hypertens 2001;19:785-794.
43. Wassner SJ. Altered growth and protein turnover in rats fed sodium-deficient diets. Pediatr Res 1989;26:608-613.
44. Wheatley CM, Rattigan S, Richards SM, Barrett EJ, Clark MG. Skeletal muscle contraction stimulates capillary recruitment and glucose uptake in insulin-resistant obese Zucker rats. Am J Physiol Endocrinol Metab 2004;287:E804-E809.
45. Hayashi T, Wojtaszewski JF, Goodyear LJ. Exercise regulation of glucose transport in skeletal muscle. Am J Physiol 1997; 273:E1039-E1051.